Skip to main content
. 2020 Apr 21;64(5):e02284-19. doi: 10.1128/AAC.02284-19

TABLE 1.

LF and antifungal MICs for yeast strains used in this studya

Species Strain MIC (μg/ml)
Lactoferrin
Antifungal drugsb
LF-S LF-D1 LF-D2 AMB NYS FLC ITC VRC 5FC
Saccharomycetes
    Clavispora lusitaniae M2002 >256 8 8 0.5 8 0.25 0.063 0.004 0.063
M5619 16 16
AMMRL1865 8 8
AMMRL1867 16 16
    Pichia kudriavzevii ATCC 6248 >256 8 8 0.5 8 16 0.25 0.25 8
AMMRL1878 8 16
M7603 8 8
M94513 8 8
    Saccharomyces cerevisiae S288c >256 8 8 0.25 8 8 0.5 0.25 0.5
M93149 8 8
    Kluyveromyces marxianus M1896 >256 16 16 1 8 0.063 0.063 0.004 4
M230550 16 16
AMMRL1826 16 16
AMMRL1816 16 16
    Candida nivariensis AMMRL1900 >256 8 8 0.25 4 4 0.25 0.25 1
    Candida bracarensis AMMRL1891 >256 8 8 0.25 4 2 0.125 0.125 0.5
    Candida glabrata CBS138 >256 8 8 0.25 4 4 0.063 0.125 0.125
M226760 8 16
M221133 8 16
M6477 8 8
    Meyerozyma guilliermondii AMMRL1830 >256 8 8 0.25 4 4 0.125 0.125 0.063
AMMRL1832 8 8
AMMRL1866 8 8
    Candida metapsilosis M1879 >256 16 16 0.25 4 4 0.125 0.125 0.25
    Candida orthopsilosis M96926 >256 16 16 0.25 4 1 0.125 0.031 0.063
M230815 16 16
M1892 16 16
M99271 16 16
    Candida dubliniensis AMMRL1881 >256 16 16 0.5 8 0.25 0.063 0.004 0.063
03-058-3327 8 8
M230642 16 16
AMMRL1792 16 16
    Candida tropicalis M230640 >256 16 8 1 8 0.5 0.125 0.031 0.25
M481 16 16
M220708 16 16
M4754 32 32
    Candida parapsilosis ATCC 22018 >256 8 8 0.5 8 2 0.125 0.125 0.5
M7486 16 16
M6865 16 16
AMMRL1875 16 16
    Candida albicans SC5314 >256 16 16 0.25 4 1 0.063 0.031 0.125
03-266-3110 16 32
04-022-3139 16 16
WM229 16 16
        Geometric mean NA 12.05 12.63 0.37 5.66 1.49 0.12 0.05 0.31
Tremellomycetes
    Cryptococcus neoformans (VNI) H99/WM148 >256 16 16 0.25 8 2 0.125 0.063 4
571 148 32 32
571 117 16 32
CH40-01/WM385 16 32
    Cryptococcus neoformans (VNII) WM556/RJ-64 >256 8 16 0.25 8 0.25 0.015 0.015 2
571 114 16 16
WM626 16 16
C3-1 8 16
    Cryptococcus neoformans (VNIII) WM628 >256 16 16 0.25 8 1 0.031 0.031 1
WM01-59 8 16
    Cryptococcus deneoformans (VNIV) JEC20 >256 8 16 0.25 8 0.5 0.008 0.015 2
JEC21 32 64
WM629 8 16
B31-2D 8 16
    Cryptococcus gattii (VGI) 2005/215 >256 16 32 0.25 8 4 0.5 0.25 1
ENV316 8 32
PNG14 8 32
V15/571_103 32 16
    Cryptococcus deuterogattii (VGII) R265 >256 16 16 0.5 8 32 0.5 0.5 2
97/170 16 16
CBS1930 16 32
ICB184 16 16
    Cryptococcus bacillisporus (VGIII) WM161 >256 16 16 0.5 8 1 0.063 0.031 8
VBP62270 8 16
97/427 16 16
B13C 32 16
    Cryptococcus tetragattii (VGIV) MMRL3013 >256 16 32 0.25 8 1 0.125 0.015 2
M250 16 16
WM779 16 16
MMRL2650 16 16
        Geometric mean NA 14.25 20.16 0.30 8.00 1.41 0.07 0.04 2.18
a

MICs for LF-D1 and LF-D2 were determined for every strain, while MICs for LF-S and antifungal drugs (AMB, NYS, FLC, ITC, VRC, and 5FC) were determined for a single strain from each species.

b

AMB, amphotericin B; NYS, nystatin; FLC, fluconazole; ITC, itraconazole; VRC, voriconazole; 5FC, 5-fluorocytosine; NA, not applicable.